Description |
pre-mRNA processing factor 18 |
fibronectin type III and SPRY domain containing 2 |
Image |
|
No pdb structure |
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU) ( 24025145)
- Craniofacial microsomia ( 26853712)
- Lupus nephritis in systemic lupus erythematosus ( 24925725)
- Post bronchodilator FEV1/FVC ratio ( 26634245)
- Skin pigmentation ( 28300201)
|
|
Interacting Genes |
81 interacting genes:
AGTRAP
AMOTL2
AP2M1
ASCC2
BEGAIN
BICD2
BLZF1
CADPS
CALCOCO2
CARD10
CARD9
CBY2
CCDC102B
CCDC136
CCDC150
CCDC57
CCNC
CDR2
CEP70
CSRNP1
DVL3
EFHC2
EVI5L
FERMT3
FSD2
GAS8
GCC1
GOLGA2
GOLGA6L9
GPBP1
GRIPAP1
HMBOX1
HOMEZ
HOOK2
HSF2BP
IKBKG
IKZF1
KANK2
KCTD7
KIFC3
KRT31
KRT34
KRT35
KRT39
KRT40
LDOC1
LZTS1
LZTS2
MCC
MDFI
MEOX2
MTUS2
NACC1
NECAB2
NINL
NUTM1
NUTM2F
OSBPL3
PDE9A
PFDN5
PIBF1
PICK1
PLEKHG4
PNMA1
PPIH
PRKAR1B
RHOU
RINT1
SCHIP1
SPRED1
STX11
TRAF2
TRIM23
TRIM27
TRIM54
TSNAX
TSNAXIP1
UBXN11
ZNF526
ZNF639
ZRANB1
|
94 interacting genes:
AQP1
ARFIP2
ATF7IP2
ATG14
ATXN7L2
BEX2
BEX3
BRD8
C1orf216
CAMSAP3
CBX8
CCDC112
CCDC120
CCDC146
CCDC187
CCHCR1
CDC73
CDK18
CORO1A
CTAG1A
CTAG1B
CWF19L2
DCX
DTNB
ENKD1
ESD
EXOC3
FAM107A
FAM110A
FAM161A
FAM50B
FAM90A1
FARS2
FMR1
HDAC4
HGS
IFT20
KANSL1
KLHL40
LATS1
LENG1
LNX1
MCRS1
MID2
MRPL11
MYBPC2
NDN
OIP5
OXNAD1
PBX3
PIK3R3
PNMA5
POLL
PPP1R18
PPP2R5D
PRPF18
PRPF31
PSMB4
RCOR3
RNF8
SCNM1
SH2D4A
SMARCE1
SNAPIN
SPATC1L
TCEANC
THAP7
TLE5
TSGA10IP
TTC23
UBTFL1
VEZF1
ZBTB38
ZC2HC1C
ZMAT2
ZNF124
ZNF20
ZNF230
ZNF35
ZNF408
ZNF410
ZNF417
ZNF490
ZNF572
ZNF580
ZNF581
ZNF587
ZNF648
ZNF76
ZNF774
ZNF777
ZNF835
ZNF837
ZSCAN26
|
Entrez ID |
8559 |
123722 |
HPRD ID |
05407 |
17291 |
Ensembl ID |
ENSG00000165630
|
ENSG00000186628
|
Uniprot IDs |
Q99633
|
A1L4K1
B7ZM05
|
PDB IDs |
2DK4
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|